-
Publication Venue For
-
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
2022
-
Pregnancy outcomes with hydroxyurea use in women with sickle cell disease..
97:603-612.
2022
-
Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium..
96:1491-1504.
2021
-
Thrombocytopenia and splanchnic thrombosis after Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic portosystemic shunting and thrombectomy..
96:1180-1182.
2021
-
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma..
96:418-427.
2021
-
Clinical characteristics of testicular extramedullary involvement in multiple myeloma..
96:E77-E81.
2021
-
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH..
96:E5-E8.
2021
-
Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials..
96:E11-E15.
2021
-
Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium..
95:1066-1074.
2020
-
Real-world effectiveness of eliglustat in treatment-naïve and switch patients enrolled in the International Collaborative Gaucher Group Gaucher Registry..
95:1038-1046.
2020
-
Isolated cerebrospinal fluid relapse of acute myeloid leukemia status post stem cell transplant: A neuroleukemiosis manifesting as polyneuropathy..
95:1001-1002.
2020
-
Characterization of the severe phenotype of pyruvate kinase deficiency.
2020
-
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects..
95:662-671.
2020
-
Hematologic findings in a large sample of patients with anorexia nervosa and bulimia nervosa..
95:E98-E101.
2020
-
Third trimester and early postpartum period of pregnancy have the greatest risk for ACS in women with SCD..
94:E328-E331.
2019
-
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes..
94:741-750.
2019
-
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors..
94:563-574.
2019
-
A multi-institutional comparison of younger and older adults with sickle cell disease..
94:E115-E117.
2019
-
Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting..
94:223-230.
2019
-
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial..
94:21-28.
2019
-
Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease..
93:1451-1460.
2018
-
The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease..
93:E391-E395.
2018
-
A common functional PIEZO1 deletion allele associates with red blood cell density in sickle cell disease patients..
93:E362-E365.
2018
-
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial..
93:1394-1401.
2018
-
A case series describing causes of death in pregnant women with sickle cell disease in a low-resource setting..
93:E167-E170.
2018
-
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management..
93:953-962.
2018
-
Physician decision making in selection of second-line treatments in immune thrombocytopenia in children..
93:882-888.
2018
-
A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)..
93:159-168.
2018
-
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia..
93:E49-E52.
2018
-
Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low-resource setting..
92:872-878.
2017
-
Recognition of early mortality in multiple myeloma by a prediction matrix..
92:915-923.
2017
-
Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry..
92:929-939.
2017
-
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia..
92:730-738.
2017
-
Thrombospondin-1 gene polymorphism is associated with estimated pulmonary artery pressure in patients with sickle cell anemia..
92:E31-E34.
2017
-
Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy..
91:1002-1007.
2016
-
Patent foramen ovale in adults with sickle cell disease and stroke..
91:E358-E360.
2016
-
"Hairy" cells in acute promyelocytic leukemia: Excess myeloperoxidase with formation of needle-shaped crystalline projections on the cytochemical stain in a case with variant morphology..
91:747-748.
2016
-
Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study..
91:687-691.
2016
-
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management..
91:529-537.
2016
-
Secondhand smoke is associated with more frequent hospitalizations in children with sickle cell disease..
91:313-317.
2016
-
Effects of hydroxyurea treatment for patients with hemoglobin SC disease..
91:238-242.
2016
-
Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials..
91:199-204.
2016
-
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy..
90:796-799.
2015
-
Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma..
90:E111-E116.
2015
-
Evidence gaps in the management of sickle cell disease: A summary of needed research..
90:273-275.
2015
-
Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry..
90:187-192.
2015
-
Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: importance of achieving treatment-free remission..
90:242-249.
2015
-
Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy..
90:139-143.
2015
-
Silent cerebral infarction, income, and grade retention among students with sickle cell anemia..
89:E188-E192.
2014
-
Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia..
89:721-725.
2014
-
Factors associated with survival in a contemporary adult sickle cell disease cohort..
89:530-535.
2014
-
Parent education and biologic factors influence on cognition in sickle cell anemia..
89:162-167.
2014
-
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial..
88:932-938.
2013
-
Recent advances in de novo CD5+ diffuse large B cell lymphoma..
88:798-802.
2013
-
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease..
88:179-184.
2013
-
Pathological bone fractures in a 20-year old athletic male with multifocal solitary plasmacytoma of bone..
87:626-627.
2012
-
Antiphospholipid syndrome: laboratory testing and diagnostic strategies..
87 Suppl 1:S75-S81.
2012
-
Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia..
87:525-528.
2012
-
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors..
87 Suppl 1:S141-S145.
2012
-
Postpartum hemorrhage: when uterotonics and sutures fail..
87 Suppl 1:S16-S22.
2012
-
Complications of implantable venous access devices in patients with sickle cell disease..
87:224-226.
2012
-
Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes..
86:E70-E73.
2011
-
Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphoma..
86:627-630.
2011
-
An unusual nodal marginal zone lymphoma with bright CD10 expression: a potential diagnostic pitfall..
85:546-548.
2010
-
Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study..
85:467-471.
2010
-
IgG-lambda plasma cell myeloma with cytoplasmic azurophilic inclusion bodies..
85:516-517.
2010
-
Informational needs assessment of non-Hodgkin lymphoma survivors and their physicians..
85:528-532.
2010
-
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up..
85:403-408.
2010
-
Prominent Dutcher body formation in a case of follicular lymphoma with BCL6 gene rearrangement and intact BCL2 gene..
85:218-219.
2010
-
Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease..
85:36-40.
2010
-
Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement..
85:79-81.
2010
-
Definitions of the phenotypic manifestations of sickle cell disease..
85:6-13.
2010
-
Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study..
85:29-35.
2010
-
Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures..
84:703-709.
2009
-
Langerhans cell histiocytosis following acute leukemia in an adult..
84:693-694.
2009
-
The excess burden of stroke in hospitalized adults with sickle cell disease..
84:548-552.
2009
-
Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience..
84:408-413.
2009
-
Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines..
84:366-370.
2009
-
D-dimer for the diagnosis of venous thromboembolism in children..
84:62-63.
2009